WA
IBB icon

Westfuller Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Westfuller Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$100K Hold
527
– – 0.04% 229
2026
Q1 		$89K Hold
527
– – 0.04% 218
2025
Q4 		$89K Hold
527
– – 0.04% 232
2025
Q3 		$76.1K Buy
+527
New +$71.9K 0.03% 249

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Westfuller Advisors's IBB Position: Q2 2026 in Review

Westfuller Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 527 shares worth $100K. The position accounts for 0.04% of the portfolio, ranked #229.

Westfuller Advisors first reported a position in IBB in Q3 2025 and has held it in 4 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Westfuller Advisors held 527 shares of iShares Biotechnology ETF worth $100K as of Q2 2026.
  • Westfuller Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
  • iShares Biotechnology ETF made up 0.04% of Westfuller Advisors's portfolio in Q2 2026, its #229 holding.
  • Westfuller Advisors first reported a position in iShares Biotechnology ETF in Q3 2025 and has held it in 4 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Westfuller Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.